SOTERA HEALTH CO (SHC) Stock Analyst Ratings
NASDAQ:SHC • US83601L1026
17.45 USD
+0.36 (+2.11%)
At close: Feb 18, 2026
17.45 USD
0 (0%)
After Hours: 2/18/2026, 8:01:51 PM
ChartMill assigns a Buy % Consensus number of 84% to SHC. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 20.85. This target is 19.46% above the current price.
- SHC was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SHC.
- In the previous month the buy percentage consensus was at a similar level.
- SHC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | RBC Capital | Reiterate | Outperform |
| 2026-01-09 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-12-18 | William Blair | Initiate | Outperform |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-05 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-05 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-05 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-04-23 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-18 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-06 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-21 | Piper Sandler | Initiate | Neutral |
| 2024-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-03 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-03-25 | Jefferies | Upgrade | Hold -> Buy |
| 2024-03-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-06 | Keybanc | Initiate | Sector Weight |
| 2024-01-25 | Barclays | Maintains | Overweight -> Overweight |
| 2023-11-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-04 | Keybanc | Maintains | Overweight -> Overweight |
SOTERA HEALTH CO / SHC FAQ
What is the price target for SHC stock?
15 analysts have analysed SHC and the average price target is 20.85 USD. This implies a price increase of 19.46% is expected in the next year compared to the current price of 17.45.
What is the consensus rating for SOTERA HEALTH CO (SHC) stock?
The consensus rating for SOTERA HEALTH CO (SHC) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.